ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut_老虎社区_美港股上老虎

ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut

investorplace2021-06-18

23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday. Here’s everything investorsneed to know about the company and it going public. ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

209

Shuanggyang
·2021-06-21
[财迷]
回复
点赞
举报
EricTan4527
·2021-06-21
Oh
回复
点赞
举报
Popcornn
·2021-06-21
Wow
回复
点赞
举报
jolinisme
·2021-06-21
Oh
回复
点赞
举报
WhinnyWinny
·2021-06-20
[Great]
回复
点赞
举报
Wongwonggg
·2021-06-20
Good
回复
点赞
举报
KS_Lee
·2021-06-20
All biotech companies are risky but also potentially jackpot material
回复
点赞
举报
JimmyLZH
·2021-06-20
Nice
回复
2
举报
GeoLegends
·2021-06-20
Nice
回复
1
举报
Brosnananana
·2021-06-20
Nice
回复
1
举报
ArkInvest
·2021-06-20
nice
回复
1
举报
KevinWan
·2021-06-20
Thanks
回复
1
举报
gary9535
·2021-06-20
WOW
回复
1
举报
ISSEY1413
·2021-06-20
Follow me. If you want to know how to complete "Trending" tigercoin task
回复
1
举报
Kaibin
·2021-06-20
[Cool]
回复
1
举报
ML808
·2021-06-20
Good advice!
回复
1
举报
113f96a0
·2021-06-20
Interesting
回复
1
举报
NgKenny
·2021-06-20
Good
回复
点赞
举报
Magthemoney
·2021-06-19
[Smile] [Strong]
回复
点赞
举报
jyau73
·2021-06-19
Huat and cool
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1135760972?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-18 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135760972","market":"us","top_or_hot":-1,"title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","media":"investorplace","content":"<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">网页链接</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ME","symbol_name":"23andMe, Inc.","start_time":0,"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","article_id":"1135760972","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","pubTimestamp":1624026807,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ME":"23andMe, Inc."},"translate_title":"《我的股票》:23andMe纳斯达克上市后投资者应了解的14件事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ME":0.9},"content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":164433705,"gmtCreate":1624232732707,"gmtModify":1634009297298,"author":{"id":"3574887418287176","authorId":"3574887418287176","name":"Shuanggyang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574887418287176","authorIdStr":"3574887418287176"},"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164433705","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":164524408,"gmtCreate":1624231011004,"gmtModify":1631890388507,"author":{"id":"3586315254285458","authorId":"3586315254285458","name":"EricTan4527","avatar":"https://static.tigerbbs.com/d44236c4ebf7d2188154b3ab2c05456a","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3586315254285458","authorIdStr":"3586315254285458"},"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164524408","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164505132,"gmtCreate":1624226013326,"gmtModify":1634009411089,"author":{"id":"3574394359789498","authorId":"3574394359789498","name":"Popcornn","avatar":"https://static.tigerbbs.com/a9963e628c84bc7aa6308556a38d7360","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574394359789498","authorIdStr":"3574394359789498"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164505132","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164265532,"gmtCreate":1624209300626,"gmtModify":1634009451825,"author":{"id":"3574936536300157","authorId":"3574936536300157","name":"jolinisme","avatar":"https://static.tigerbbs.com/1091498047118bdffdd80375a3e55929","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3574936536300157","authorIdStr":"3574936536300157"},"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164265532","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164640569,"gmtCreate":1624203396451,"gmtModify":1634009517405,"author":{"id":"3583917916714733","authorId":"3583917916714733","name":"WhinnyWinny","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583917916714733","authorIdStr":"3583917916714733"},"htmlText":"[Great]&nbsp;","listText":"[Great]&nbsp;","text":"[Great]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164640569","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164808406,"gmtCreate":1624187440905,"gmtModify":1634009672622,"author":{"id":"3586849282716963","authorId":"3586849282716963","name":"Wongwonggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3586849282716963","authorIdStr":"3586849282716963"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164808406","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164132238,"gmtCreate":1624178847024,"gmtModify":1634009740999,"author":{"id":"3579578865458065","authorId":"3579578865458065","name":"KS_Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579578865458065","authorIdStr":"3579578865458065"},"htmlText":"All biotech companies are risky but also potentially jackpot material&nbsp;","listText":"All biotech companies are risky but also potentially jackpot material&nbsp;","text":"All biotech companies are risky but also potentially jackpot material","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164132238","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165469350,"gmtCreate":1624155088870,"gmtModify":1634010186250,"author":{"id":"3586863844711073","authorId":"3586863844711073","name":"JimmyLZH","avatar":"https://static.tigerbbs.com/7ecc6de8a47b65c54bcbdca5fe23b697","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586863844711073","authorIdStr":"3586863844711073"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165469350","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165413603,"gmtCreate":1624154702302,"gmtModify":1634010204655,"author":{"id":"3584748254057781","authorId":"3584748254057781","name":"GeoLegends","avatar":"https://static.tigerbbs.com/9b58fc6a4f5903eabaf4a377779a7a2f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584748254057781","authorIdStr":"3584748254057781"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165413603","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165437577,"gmtCreate":1624154639199,"gmtModify":1634010207573,"author":{"id":"3578737755692245","authorId":"3578737755692245","name":"Brosnananana","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3578737755692245","authorIdStr":"3578737755692245"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165437577","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165584651,"gmtCreate":1624151714573,"gmtModify":1634010281963,"author":{"id":"3559463359065359","authorId":"3559463359065359","name":"ArkInvest","avatar":"https://static.tigerbbs.com/6dfcf7df27430673110d69ba1374e540","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3559463359065359","authorIdStr":"3559463359065359"},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165584651","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165589039,"gmtCreate":1624151403321,"gmtModify":1634010288070,"author":{"id":"3586164795006867","authorId":"3586164795006867","name":"KevinWan","avatar":"https://static.tigerbbs.com/69d530508883f388a4a626340300ed5a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3586164795006867","authorIdStr":"3586164795006867"},"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165589039","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165508258,"gmtCreate":1624149911274,"gmtModify":1634010322221,"author":{"id":"3586300229783457","authorId":"3586300229783457","name":"gary9535","avatar":"https://static.tigerbbs.com/450bffc6ea7d58c21b47fcc86060b0d4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586300229783457","authorIdStr":"3586300229783457"},"htmlText":"WOW","listText":"WOW","text":"WOW","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165508258","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165252200,"gmtCreate":1624148600900,"gmtModify":1634010349453,"author":{"id":"3580024367177542","authorId":"3580024367177542","name":"ISSEY1413","avatar":"https://static.tigerbbs.com/3aae359514ad4455bfc28cf62f608a5e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3580024367177542","authorIdStr":"3580024367177542"},"htmlText":"Follow me. If you want to know how to complete \"Trending\" tigercoin task","listText":"Follow me. If you want to know how to complete \"Trending\" tigercoin task","text":"Follow me. If you want to know how to complete \"Trending\" tigercoin task","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165252200","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165264814,"gmtCreate":1624147597138,"gmtModify":1634010366819,"author":{"id":"3561084317650470","authorId":"3561084317650470","name":"Kaibin","avatar":"https://static.tigerbbs.com/b73a11c3a24271721d07c8c1d1c6242c","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3561084317650470","authorIdStr":"3561084317650470"},"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165264814","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165671394,"gmtCreate":1624141918718,"gmtModify":1634010428134,"author":{"id":"3582359360248748","authorId":"3582359360248748","name":"ML808","avatar":"https://static.tigerbbs.com/f601c68849ffbac8b7679f40f1471368","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582359360248748","authorIdStr":"3582359360248748"},"htmlText":"Good advice!","listText":"Good advice!","text":"Good advice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165671394","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165664994,"gmtCreate":1624130690418,"gmtModify":1634010461194,"author":{"id":"3574919372586068","authorId":"3574919372586068","name":"113f96a0","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574919372586068","authorIdStr":"3574919372586068"},"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165664994","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165843650,"gmtCreate":1624119226270,"gmtModify":1634010532861,"author":{"id":"3582778356971864","authorId":"3582778356971864","name":"NgKenny","avatar":"https://static.tigerbbs.com/4fdae3e0bdca8d3a33e7f9d619f0dc88","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582778356971864","authorIdStr":"3582778356971864"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165843650","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165315735,"gmtCreate":1624095429727,"gmtModify":1634010735144,"author":{"id":"3587012591464862","authorId":"3587012591464862","name":"Magthemoney","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3587012591464862","authorIdStr":"3587012591464862"},"htmlText":"[Smile]&nbsp;[Strong]&nbsp;","listText":"[Smile]&nbsp;[Strong]&nbsp;","text":"[Smile] [Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165315735","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165966057,"gmtCreate":1624088054479,"gmtModify":1634010808672,"author":{"id":"4087190501410390","authorId":"4087190501410390","name":"jyau73","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087190501410390","authorIdStr":"4087190501410390"},"htmlText":"Huat and cool","listText":"Huat and cool","text":"Huat and cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165966057","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","kind":"news","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":209,"commentSize":82,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}